Exact Mass: 697.3590796
Exact Mass Matches: 697.3590796
Found 103 metabolites which its exact mass value is equals to given mass value 697.3590796,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Rifamycin
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics J - Antiinfectives for systemic use > J04 - Antimycobacterials > J04A - Drugs for treatment of tuberculosis > J04AB - Antibiotics D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use A member of the class of rifamycins that exhibits antibiotic and antitubercular properties. S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives Same as: D02549
Bz-Ile-glu-gly-arg-pna
2-O-(Indol-3-acetyl)-D-glucopyranose-trimethylsilylether
C31H59NO7Si5 (697.3137704000001)
4-O-(Indol-3-acetyl)-D-glucopyranose-trimethylsilylether
C31H59NO7Si5 (697.3137704000001)
2-O-Indol-3-acetylmyrinosit-trimethylsilylether
C31H59NO7Si5 (697.3137704000001)
6-O-(Indol-3-acetyl)-D-glucopyranose-trimethylsilylether
C31H59NO7Si5 (697.3137704000001)
Tas-108
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C1892 - Chemopreventive Agent
Betalutin
D007155 - Immunologic Factors > D007136 - Immunoglobulins D007155 - Immunologic Factors > D000906 - Antibodies
N-(2-aminophenyl)-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]heptanediamide
C37H46F3N5O5 (697.3450861999999)
CID 21775293
D009676 - Noxae > D011042 - Poisons > D008235 - Lyngbya Toxins D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins
2-amino-3-[[3-dodecanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
2-amino-3-[[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
2-amino-3-[[3-decanoyloxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
2-amino-3-[[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-octanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
(2S)-2-amino-3-[[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
(2S)-2-amino-3-[[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
(2S)-2-amino-3-[[(2S)-3-decanoyloxy-2-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
(2R)-2-amino-3-[[(2S)-2-decanoyloxy-3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
(2S)-2-amino-3-[[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
(2S)-2-amino-3-[[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-tetradecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
QWF Peptide
C38H43N5O8 (697.3111478000001)
QWF Peptide (Compound 4a) is a substance P antagonist with an IC50 of 0.09 μM. QWF Peptide antagonizes the SP-induced contraction of isolated guinea pig trachea strips with an IC50 of 4.7 μM[1]. QWF Peptide (Compound 4a) is a substance P antagonist with an IC50 of 0.09 μM. QWF Peptide antagonizes the SP-induced contraction of isolated guinea pig trachea strips with an IC50 of 4.7 μM[1].
9-benzyl-11,14,17,20-tetrahydroxy-18-(1h-indol-3-ylmethyl)-15-(2-methylpropyl)-1,7,10,13,16,19-hexaazatricyclo[19.3.0.0³,⁷]tetracosa-10,13,16,19-tetraene-2,8-dione
[(2s,8s,11s,14r,17s)-17-[(2r)-butan-2-yl]-3,6,9,12,15,18-hexahydroxy-8-(1h-indol-3-ylmethyl)-11,14-bis(2-methylpropyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]acetic acid
C35H51N7O8 (697.3798926000001)
(2s,3r,4r,5r,6r)-2,4,5-tris[(trimethylsilyl)oxy]-6-{[(trimethylsilyl)oxy]methyl}oxan-3-yl 2-[1-(trimethylsilyl)indol-3-yl]acetate
C31H59NO7Si5 (697.3137704000001)
2,4,5-tris[(trimethylsilyl)oxy]-6-{[(trimethylsilyl)oxy]methyl}oxan-3-yl 2-[1-(trimethylsilyl)indol-3-yl]acetate
C31H59NO7Si5 (697.3137704000001)
[1-(trimethylsilyl)indol-3-yl]methyl 2-{3,4,5,6-tetrakis[(trimethylsilyl)oxy]oxan-2-yl}acetate
C31H59NO7Si5 (697.3137704000001)
(7e,13e,15e,17e,19e)-21-[(4-amino-3,5-dihydroxy-6-methyloxan-2-yl)oxy]-1,3,5,6,25-pentahydroxy-11,12-dimethyl-9-oxo-10,27-dioxabicyclo[21.3.1]heptacosa-7,13,15,17,19-pentaene-24-carboxylic acid
C34H51NO14 (697.3309386000001)
(7s,9e,11s,12r,13s,14r,15r,16r,17s,18s,19e,21z)-2,15,17,23,27,29-hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6-oxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1(29),2,4,9,19,21,23,25,27-nonaen-13-yl acetate
(2r)-3-hydroxy-2-{[hydroxy({5-hydroxy-2-[2-(2-{2-[(2s,3s)-2-hydroxy-3-methylpentanoyl]-1,2-diazinane-3-carbonyl}-1,2-diazinane-3-carbonyl)-1,2-diazinane-3-carbonyl]-1,2-diazinan-3-yl})methylidene]amino}-2-methylpropanoic acid
(3e,5s,6r,7s,9s,11e,13z,15s,16r)-15-({[(2r,3r,4s,5s,6r)-4,5-dihydroxy-3-methoxy-6-methyloxan-2-yl]oxy}methyl)-6-{[(2r,3r,4s,6s)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-16-ethyl-15-hydroxy-5,7,9-trimethyl-1-oxacyclohexadeca-3,11,13-triene-2,10-dione
[1-(trimethylsilyl)indol-3-yl]methyl (2s,3r,4s,5r,6s)-4,5,6-tris[(trimethylsilyl)oxy]-2-{[(trimethylsilyl)oxy]methyl}oxane-3-carboxylate
C31H59NO7Si5 (697.3137704000001)
(3s,9s,15s,18s,21s)-9-benzyl-11,14,17,20-tetrahydroxy-18-(1h-indol-3-ylmethyl)-15-(2-methylpropyl)-1,7,10,13,16,19-hexaazatricyclo[19.3.0.0³,⁷]tetracosa-10,13,16,19-tetraene-2,8-dione
(2s)-2-[(2s)-2-[(2e)-3-methoxy-n-methylbut-2-enamido]-3-(4-methoxyphenyl)-n-methylpropanamido]-n,4-dimethyl-n-[(2s,3s)-3-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl]pentanamide
15-{[(4,5-dihydroxy-3-methoxy-6-methyloxan-2-yl)oxy]methyl}-6-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-16-ethyl-15-hydroxy-5,7,9-trimethyl-1-oxacyclohexadeca-3,11,13-triene-2,10-dione
(1r,3s,5r,6r,7z,11r,12s,13z,15z,17z,19z,21r,23s,24r,25s)-21-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,5,6,25-pentahydroxy-11,12-dimethyl-9-oxo-10,27-dioxabicyclo[21.3.1]heptacosa-7,13,15,17,19-pentaene-24-carboxylic acid
C34H51NO14 (697.3309386000001)
[1-(trimethylsilyl)indol-3-yl]methyl 4,5,6-tris[(trimethylsilyl)oxy]-2-{[(trimethylsilyl)oxy]methyl}oxane-3-carboxylate
C31H59NO7Si5 (697.3137704000001)
(2s)-2-[(2s)-2-[(2e)-3-methoxy-n-methylbut-2-enamido]-3-(4-methoxyphenyl)-n-methylpropanamido]-n,4-dimethyl-n-[(2s,3s)-3-methyl-1-oxo-1-[(2s)-2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl]pentanamide
(3e,6s,7r,9s,11e,13z,15s,16s)-6-{[(2s,3s,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-16-ethyl-15-hydroxy-15-({[(2s,3r,4s,5r,6r)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxy}methyl)-7,9-dimethyl-1-oxacyclohexadeca-3,11,13-triene-2,10-dione
2-[2-(3-methoxy-n-methylbut-2-enamido)-3-(4-methoxyphenyl)-n-methylpropanamido]-n,4-dimethyl-n-{3-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl}pentanamide
(7s,9e,11s,12r,13s,14r,15r,16r,17s,18s)-2,15,17,23,27,29-hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6-oxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1(29),2,4,9,19,21,23,25,27-nonaen-13-yl acetate
[1-(trimethylsilyl)indol-3-yl]methyl 2-[(2r,3r,4s,5r,6r)-3,4,5,6-tetrakis[(trimethylsilyl)oxy]oxan-2-yl]acetate
C31H59NO7Si5 (697.3137704000001)